PDGF/PDGFR signalling is an attractive target for anti-cancer therapy; it has a pleiotropic role on the tumour microenvironment, principally in vascular maturation, but it also has direct effects on tumour cells and hypoxia [4], [7], [8], [25]. The gene discussed is PDGFRB; the disease is cancer.